Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03000166 · ClinicalTrials.gov registry record · NA

Step-Up Intervention for Self-Management of Fatigue in Young Adults Receiving Chemotherapy

A NA study of Young Adult, Cancer, Physical Activity, sponsored by University of Wisconsin, Milwaukee.

Completed
Registry status
NA
Development phase
47
Enrollment target
2
Study locations

NCT03000166: Completed NA study of Young Adult, Cancer, Physical Activity, sponsored by University of Wisconsin, Milwaukee.

NCT03000166 is a NA study of Young Adult, Cancer, Physical Activity that has completed, run by University of Wisconsin, Milwaukee. The registered enrollment target is 47 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03000166, a NA study of Young Adult, Cancer, Physical Activity, has completed, sponsored by University of Wisconsin, Milwaukee.

COMPLETED
Registry status
NA
Development phase
47 participants
Enrollment target
2
Study locations

Study Summary

The purpose of the study is to determine the impact of a physical activity intervention on the self-management of fatigue in young adults receiving chemotherapy. Half of the participants will receive an intervention which includes education and resources to set physical activity goals and monitor progress toward goals.

Primary Outcome

Physical Activity Assessment Inventory (Haas \& Northam, 2010) The scale measures confidence to be physically active under various conditions. Scores range from 0=cannot do at all to 100=certain can do.

Interventions

  • BEHAVIORAL Step-Up Intervention

Study Locations (2)

Wisconsin

  • Froedtert Hospital - Milwaukee
  • Children's Hospital of Wisconsin - Milwaukee

Trial Details

FieldValue
Enrollment Target 47 participants
Start Date 2017-01-31
Est. Completion 2019-07-16
Phase NA
University of Wisconsin, Milwaukee

21 total trials

What the finished NCT03000166 record still lists

NCT03000166 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 47 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Young Adult, Cancer, Physical Activity appearing as the primary indexed condition, and to 1 intervention - of which Step-Up Intervention is the first listed.

NCT03000166 reports a single indexed study location in Wisconsin.

Frequently Asked Questions

What is clinical trial NCT03000166 about?

NCT03000166 is a clinical study titled "Step-Up Intervention for Self-Management of Fatigue in Young Adults Receiving Chemotherapy". The purpose of the study is to determine the impact of a physical activity intervention on the self-management of fatigue in young adults receiving chemotherapy. Half of the participants will receive an intervention which includes education and resources to set physical activity goals and monitor pr...

What is the current status of trial NCT03000166?

This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2017-01-31. Estimated completion is 2019-07-16.

What conditions does trial NCT03000166 study?

This clinical trial studies the following conditions: Young Adult, Cancer, Physical Activity.

What interventions are being tested in trial NCT03000166?

The interventions under investigation include: Step-Up Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT03000166?

This trial is sponsored by University of Wisconsin, Milwaukee, which has 21 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03000166 being conducted?

This trial has 2 study locations across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT03000166's enrollment target sits among peer trials

47 1400th of 2000 higher than 599 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03313011 · 47 participants

    The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech

  • NCT03467516 · 47 participants · Phase 2

    Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma

  • NCT03886662 · 47 participants · Phase 1

    A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)

  • NCT04013802 · 47 participants · Phase 1

    TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03000166, the US trial registry maintained by the National Library of Medicine. NCT03000166 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.